Microtissues®

Summary

Published in Cellular and Molecular Bioengineering (2021), this peer-reviewed study used 3D Petri Dish® micro-molds to form scaffold-free 3D microtissues. Full citation: Soepriatna, Arvin H., et al. Human Atrial Cardiac Microtissues for Chamber-Specific Arrhythmic Risk Assessment

❤️ Cardiovascular

Human Atrial Cardiac Microtissues for Chamber-Specific Arrhythmic Risk Assessment

Cellular and Molecular Bioengineering 2021 Soepriatna, Arvin H., et al
Cite as: Soepriatna, Arvin H., et al. Human Atrial Cardiac Microtissues for Chamber-Specific Arrhythmic Risk Assessment. Cellular and Molecular Bioengineering (2021). doi:10.1007/s12195-021-00703-x doi.org/10.1007/s12195-021-00703-x

Research Overview

Atrial fibrillation is the most prevalent electrical conduction disorder, yet the mechanisms behind atrial arrhythmias remain elusive — partly because most cardiac models use ventricular cells.

This study developed a robust in vitro model of 3D atrial microtissue from human iPSC-derived cardiomyocytes, evaluating chamber-specific chemical responses experimentally and computationally. Atrial and ventricular cardiomyocytes were differentiated from GCaMP6f-expressing iPSCs, action potential activity assessed by fluorescence imaging, and self-assembling microtissues formed from lactate-purified cardiomyocytes with 5% human cardiac fibroblasts, then electrically stimulated.

Key Discoveries

  • Chamber-specific 3D atrial microtissues distinguished from ventricular models
  • Self-assembled from lactate-purified iPSC-cardiomyocytes with 5% cardiac fibroblasts
  • GCaMP6f fluorescence imaging plus computational modeling assessed arrhythmic risk